Breaking News Instant updates and real-time market news.

NFLX

Netflix

$265.14

-17.66 (-6.24%)

, PANW

Palo Alto Networks

$175.11

-6.73 (-3.70%)

13:20
12/09/18
12/09
13:20
12/09/18
13:20

Netflix, Palo Alto offer growth at a discount, Barron's says

As stocks search for a bottom, many high-quality tech and communications-services names are starting to look like attractive growth opportunities, priced at bargain-basement levels, Bill Luby writes in this week's edition of Barron's. Two are particularly alluring because of the extent of their falls and their growth prospects: Netflix (NFLX) in communications services and Palo Alto Networks (PANW) in the cybersecurity segment of the computer networking industry, the report notes. Reference Link

NFLX

Netflix

$265.14

-17.66 (-6.24%)

PANW

Palo Alto Networks

$175.11

-6.73 (-3.70%)

  • 13

    Dec

  • 19

    Dec

  • 09

    Jan

  • 10

    Jan

NFLX Netflix
$265.14

-17.66 (-6.24%)

11/16/18
IMPC
11/16/18
NO CHANGE
Target $459
IMPC
Outperform
Imperial parts with consensus, raises Netflix estimates for Q4
Imperial Capital analyst David Miller says he is "parting with consensus and guidance" and raising his Q4 domestic subscriber net additions estimate for Netflix from 1.50M to 1.55M and international subscriber net additions estimate from 6.10M to 6.25M. The reason is due not only to returning episodic installments of "House of Cards" and "Narcos," but also series originally intended for international audiences that are "quickly finding viewers" in the U.S., Miller tells investors in a research note. Examples are "Elite," filmed in Spain with an all-Spanish cast, "3%," a sci-fi drama filmed and set in Brazil, The Rain, another drama filmed and set in Denmark, and Dark, a crime drama filmed and set in German, says the analyst. Miller also increased his Q4 estimate for revenue to $4.22B and for net income to 28c per share from 26c. Consensus estimates currently sit at $4.20B and 24c per share, he points out. Miller keeps an Outperform rating on Netflix with a $459 price target, which represents 58% upside from current share levels.
11/16/18
MKMP
11/16/18
NO CHANGE
Target $415
MKMP
Buy
Netflix, Amazon price targets raised at MKM Partners
MKM Partners analyst Rob Sanderson raised his price targets on Buy rated Netflix (NFLX) and Amazon (AMZN) to $415 from $395 and $2,240 from $2,215 respectively as part of his broader research note titled "Victims of Risk-off Environment; Recommend Buying Weakness". The analyst states that these stocks have been among the weaker performers in the underperforming Internet sector, but should become "excellent performers" over the next 12 months if his view attributing the recent correction in the broader market to a late-cycle pause amidst geo-political uncertainty and Fed concerns proves to be correct. As part of this research note, Sanderson also keeps his Buy rating on Spotify (SPOT) but lowers its price target to $200 from $245, applying a 25-times forward earnings multiple in rolling out his valuation to 2022, with added currency related pressure against the "much less contentious" expected renewal rates in 2019.
11/29/18
NEED
11/29/18
INITIATION
Target $20
NEED
Buy
comScore resumed with a Buy at Needham
Needham analyst Laura Martin resumed coverage of comScore (SCOR) with a Buy rating and $20 price target. The analyst recommends purchase of the stock at current price levels saying comScore is a pure-play way to invest in the shift toward streaming and over-the-top viewing. The company offers monetization at a "much lower valuation" than other over-the-top alternatives such as Netflix (NFLX), Roku (ROKU) and Trade Desk (TTD), Martin tells investors in a research note.
12/07/18
RBCM
12/07/18
NO CHANGE
Target $450
RBCM
Outperform
Netflix seeing 'consistent satisfaction trends', says RBC Capital
RBC Capital analyst Mark Mahaney kept his Outperform rating and $450 price target on Netflix after reviewing the findings from his quarterly survey of over 1,500 respondents. The analyst notes that the company's penetration levels have gone up to 59% from 56% in November and that 69% of its users are "Extremely" or "Very Satisfied", which is consistent with positive results of the past 6 quarters. On the down side, Mahaney notes that 9.4% of subscriptions indicated that they are "very" or "extremely likely" to cancel, which is the highest level in the last 27 surveys.
PANW Palo Alto Networks
$175.11

-6.73 (-3.70%)

11/30/18
FBCO
11/30/18
NO CHANGE
Target $160
FBCO
Underperform
Palo Alto Networks price target cut to $160 from $185 at Credit Suisse
Credit Suisse analyst Brad Zelnick reiterated an Underperform rating on Palo Alto Networks and cut his price target to $160 following the company's "mixed" Q1 results. In a research note to investors, Zelnick says the disparity between product and billings performance continues to suggest an especially strong refresh dynamic, and while he maintains respect for Palo Alto's market leadership, strong execution and superlative messaging, he believes his secular call is just beginning to play out as firewalls cede relevance in a cloud-first world.
11/30/18
MAXM
11/30/18
NO CHANGE
Target $280
MAXM
Buy
Palo Alto Networks price target raised to $280 from $274 at Maxim
Maxim analyst Nehal Chokshi raised his price target on Palo Alto Networks to $280 and kept his Buy rating after "another beat and raise quarter", saying the company's strong results were driven by sequential subscription revenue growth. The analyst adds that the above-consensus guidance was the factor of the "uniqueness" of the company's Application Framework. Chokshi is also positive on Palo Alto Networks' CEO plan to extend its business "from security to the intersection of security and AI".
11/30/18
BMOC
11/30/18
NO CHANGE
Target $205
BMOC
Market Perform
Palo Alto Networks price target lowered to $205 from $260 at BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on Palo Alto Networks to $205 and kept his Market Perform rating, saying that while the company beat on Q1 earnings, its billings were in line, "which is a downtick from the outperformance in prior quarters". The analyst believes that the free cash flow multiple on Palo Alto Networks is "reasonable", but also warns about the overhang on the stock lingering because of the potential for M&A. Bachman adds that he is concerned by the "durability" of the company's billings growth, adding that his price target reduction reflects "lower free cash flow estimates and a lower multiple due to a reduced equity risk environment".
11/30/18
GABE
11/30/18
UPGRADE
GABE
Buy
Palo Alto Networks upgraded to Buy from Hold at Gabelli
Gabelli analyst Hendi Susanto upgraded Palo Alto to Buy citing recent shares weakness. The analyst views current valuation as attractive and remains favorable on Palo Alto's market leadership, technology platform, and competitive security platform.

TODAY'S FREE FLY STORIES

AER

AerCap

$61.01

0.72 (1.19%)

10:50
11/12/19
11/12
10:50
11/12/19
10:50
Conference/Events
AerCap management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WBA

Walgreens Boots Alliance

$62.35

0.09 (0.14%)

10:46
11/12/19
11/12
10:46
11/12/19
10:46
Recommendations
Walgreens Boots Alliance analyst commentary  »

Walgreens Boots could be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 22

    Nov

QSR

Restaurant Brands

$67.39

-0.15 (-0.22%)

10:45
11/12/19
11/12
10:45
11/12/19
10:45
Options
Restaurant Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

F

Ford

$9.11

0.03 (0.33%)

, GM

General Motors

$38.89

0.18 (0.46%)

10:38
11/12/19
11/12
10:38
11/12/19
10:38
Periodicals
Trump expected to extend deadline for EU car tariffs, Bloomberg says »

The Trump administration…

F

Ford

$9.11

0.03 (0.33%)

GM

General Motors

$38.89

0.18 (0.46%)

HMC

Honda

$29.35

0.15 (0.51%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$145.00

-0.07 (-0.05%)

TSLA

Tesla

$348.78

3.71 (1.08%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.21

0.1 (0.62%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 04

    Feb

KSS

Kohl's

$56.48

-0.56 (-0.98%)

10:35
11/12/19
11/12
10:35
11/12/19
10:35
Options
Kohl's put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

10:35
11/12/19
11/12
10:35
11/12/19
10:35
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

DIS

Disney

$139.04

2.3 (1.68%)

10:31
11/12/19
11/12
10:31
11/12/19
10:31
Hot Stocks
Disney says Disney+ 'exceeded our high expectations,' working on glitches »

Disney+ Help tweeted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$32.77

0.01 (0.03%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Options
Kraft Heinz call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Roche to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

REPL

Replimune Group

$17.24

0.11 (0.64%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Replimune Group participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
UBS technology analysts to hold an analyst/industry conference call »

Technology Analysts…

LH

LabCorp

$165.45

-0.29 (-0.17%)

10:23
11/12/19
11/12
10:23
11/12/19
10:23
Syndicate
Breaking Syndicate news story on LabCorp »

LabCorp files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

, TEVA

Teva

$9.36

0.03 (0.32%)

10:21
11/12/19
11/12
10:21
11/12/19
10:21
On The Fly
JPMorgan gets less bearish on Xerox among today's top calls on Wall Street »

Check out today's top…

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

TEVA

Teva

$9.36

0.03 (0.32%)

AMRX

Amneal Pharmaceuticals

$2.69

0.05 (1.89%)

XRX

Xerox

$38.05

-0.28 (-0.73%)

HPQ

HP Inc.

$19.33

-0.31 (-1.58%)

AMAT

Applied Materials

$56.81

0.21 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 26

    Nov

  • 05

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

UCBJY

UCB

$0.00

(0.00%)

10:20
11/12/19
11/12
10:20
11/12/19
10:20
Conference/Events
UCB participates in a conference call with JPMorgan »

European Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$19.92

3.02 (17.87%)

10:18
11/12/19
11/12
10:18
11/12/19
10:18
On The Fly
Analysts see good odds of Amarin's Vascepa label expansion after docs posted »

Stifel analyst Derek…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/12/19
11/12
10:17
11/12/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

, CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

STOK

Stoke Therapeutics

$30.87

1.04 (3.49%)

BMRN

BioMarin

$75.96

0.72 (0.96%)

BIIB

Biogen

$291.50

-2.41 (-0.82%)

AMGN

Amgen

$223.35

2.66 (1.21%)

CTVA

Corteva

$27.06

0.32 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

  • 09

    Dec

CSX

CSX

$72.89

-1.04 (-1.41%)

, ETN

Eaton

$91.78

-0.09 (-0.10%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Initiation
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CSX

CSX

$72.89

-1.04 (-1.41%)

ETN

Eaton

$91.78

-0.09 (-0.10%)

AMRX

Amneal Pharmaceuticals

$2.71

0.07 (2.65%)

ALB

Albemarle

$67.47

-0.25 (-0.37%)

BOX

Box

$15.93

-0.52 (-3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 26

    Nov

  • 12

    Dec

ARGO

Argo Group

$63.82

2.54 (4.14%)

, LYV

Live Nation

$64.79

0.32 (0.50%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

ARGO

Argo Group

$63.82

2.54 (4.14%)

LYV

Live Nation

$64.79

0.32 (0.50%)

RCII

Rent-A-Center

$23.13

0.78 (3.49%)

CRWD

Crowdstrike

$47.25

1.07 (2.32%)

TEVA

Teva

$9.40

0.07 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 12

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$138.17

1.43 (1.05%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Periodicals
Disney tells CNBC streaming service launch exceeds 'high expectations' »

CNBC reported via Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.90

-0.01 (-0.17%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

IDRA

Idera Pharmaceuticals

$2.29

0.06 (2.69%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Conference/Events
Idera Pharmaceuticals participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.